A retrospective study on adherence to secondary prevention medications after coronary bypass surgery.
Leon Arnar HeitmannIngibjorg Jona GudmundsdottirFreyja JónsdóttirTomas GudbjartssonMartin Ingi SigurdssonPublished in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2022)
Non-adherence to medical therapy after coronary artery bypass surgery is common. Patients with a higher burden of frailty and patients naive to the medical treatment of coronary artery disease should be a target group for efforts to increase medication adherence.
Keyphrases
- coronary artery bypass
- coronary artery disease
- percutaneous coronary intervention
- minimally invasive
- end stage renal disease
- healthcare
- ejection fraction
- newly diagnosed
- chronic kidney disease
- coronary artery bypass grafting
- coronary artery
- acute coronary syndrome
- prognostic factors
- cardiovascular events
- heart failure
- stem cells
- type diabetes
- mesenchymal stem cells
- patient reported outcomes
- atrial fibrillation
- insulin resistance